First Personal Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-867
Closed -$12K – 1022
2018
Q1
$12K Sell
867
-131
-13% -$1.94K ﹤0.01% 754
2017
Q4
$15K Sell
998
-64
-6% -$899 ﹤0.01% 712
2017
Q3
$13K Sell
1,062
-113
-10% -$1.44K ﹤0.01% 665
2017
Q2
$14K Buy
1,175
+785
+201% +$9.77K ﹤0.01% 653
2017
Q1
$6K Hold
390
– – ﹤0.01% 789
2016
Q4
$6K Buy
+390
New +$7.07K ﹤0.01% 815

Other funds holding HZNP

First Personal Financial Services's HZNP Position: Q2 2018 in Review

First Personal Financial Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2018, closing a stake of 867 shares — an estimated $12K sold.

First Personal Financial Services first reported a position in HZNP in Q4 2016 and held it in 6 quarters. The position peaked at $15K in Q4 2017. 204 funds tracked by Wall St. Rank hold HZNP as of Q2 2018.

  • First Personal Financial Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • First Personal Financial Services sold 867 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2018, an estimated $12K.
  • First Personal Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 6 quarters.
  • First Personal Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15K in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2018.

Based on First Personal Financial Services's 13F filing for Q2 2018, filed 7 Aug 2018.